SCHEMBL7965425

SCHEMBL7965425

CNC(=O)c1ccc(C=CC(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c3nc(C)n4Cc3ccccc3)c2Cl)cc1

nearest known ligand 0.88

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 18/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8049452 0.94 BDKRB2 (1.00) BDKRB2
SCHEMBL7977365 0.94 BDKRB2 (1.00) BDKRB2
SCHEMBL7977407 0.91 BDKRB2 (1.00) BDKRB2
SCHEMBL7977402 0.91 BDKRB2 (1.00) BDKRB2
SCHEMBL7978857 0.89 BDKRB2 (0.85) BDKRB2
SCHEMBL7978858 0.89 BDKRB2 (0.85) BDKRB2
SCHEMBL7975538 0.87 BDKRB2 (0.83) BDKRB2
SCHEMBL7975534 0.87 BDKRB2 (0.83) BDKRB2
SCHEMBL7978897 0.87 BDKRB2 (0.83) BDKRB2
SCHEMBL7978899 0.87 BDKRB2 (0.83) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed